期刊
FEBS LETTERS
卷 586, 期 2, 页码 163-168出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2011.11.034
关键词
Breast cancer; Drug resistance; Methylation; 14-3-3 sigma; Akt; p53
资金
- National Natural Science Foundation of China [30873088]
- Ministry of Education of China [200805330009]
We previously demonstrated that 14-3-3 sigma was downregulated in 5-fluorouracil (5-Fu)-resistant MCF-7 breast cancer cells (MCF-7/5-Fu). Here, we found that stably enhanced 14-3-3 sigma expression strengthened the effects of 5-Fu, Mitoxantrone and cDDP. 14-3-3 sigma stabilised the p53 protein and bound Akt to inhibit its activity and its downstream targets: survivin, Bcl-2 and NF-kappa B-p50. In addition, decreased p53 expression, but not promoter hypermethylation, was responsible for the downregulation of 14-3-3 sigma in MCF-7/5-Fu cells. Meanwhile, initial treatments with high concentrations of 5-Fu clearly induced 14-3-3 sigma and p53 expression in a time-dependent manner. 14-3-3 sigma-mediated molecular events that synergise with p53 may play important roles in the chemotherapy of breast cancer. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据